Cell or stem cell-derived products such as stem cell-based regenerative treatments and CAR-T cell therapies have seen increasing use in treatment of blood cancers such as leukemias and lymphomas; the Centre’s move is aimed at strengthening regulatory oversight of such advanced and emerging medical technologies
Cell or stem cell-derived products such as stem cell-based regenerative treatments and CAR-T cell therapies have seen increasing use in treatment of blood cancers such as leukemias and lymphomas; the Centre’s move is aimed at strengthening regulatory oversight of such advanced and emerging medical technologies
<iframe src="https://hindustansphere.com/embed/cluster/beb9eb59f1a9ef259dadc8aece66f8a42abf48e8" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Centre amends Drugs Rules, 1945 to ensure uniform regulation of advance cell and gene therapies"></iframe>
Cell or stem cell-derived products such as stem cell-based regenerative treatments and CAR-T cell therapies have seen increasing use in treatment of blood cancers such as leukemias and lymphomas; the Centre’s move is aimed at strengthening regulatory oversight of such advanced and emerging medical technologies
Cell or stem cell-derived products such as stem cell-based regenerative treatments and CAR-T cell therapies have seen increasing use in treatment of blood cancers such as leukemias and lymphomas; the Centre’s move is aimed at strengthening regulatory oversight of such advanced and emerging medical technologies
